Logo image of AMST

AMESITE INC (AMST) Stock Fundamental Analysis

NASDAQ:AMST - Nasdaq - US0310942042 - Common Stock - Currency: USD

2.92  +0.09 (+3.18%)

After market: 2.8001 -0.12 (-4.11%)

Fundamental Rating

3

Taking everything into account, AMST scores 3 out of 10 in our fundamental rating. AMST was compared to 72 industry peers in the Diversified Consumer Services industry. While AMST has a great health rating, there are worries on its profitability. AMST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year AMST has reported negative net income.
AMST had a negative operating cash flow in the past year.
In the past 5 years AMST always reported negative net income.
In the past 5 years AMST always reported negative operating cash flow.
AMST Yearly Net Income VS EBIT VS OCF VS FCFAMST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -101.57%, AMST is doing worse than 88.89% of the companies in the same industry.
AMST has a worse Return On Equity (-107.50%) than 66.67% of its industry peers.
Industry RankSector Rank
ROA -101.57%
ROE -107.5%
ROIC N/A
ROA(3y)-100.1%
ROA(5y)-93.27%
ROE(3y)-118.05%
ROE(5y)-118.38%
ROIC(3y)N/A
ROIC(5y)N/A
AMST Yearly ROA, ROE, ROICAMST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200

1.3 Margins

AMST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMST Yearly Profit, Operating, Gross MarginsAMST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -10K -20K -30K

More info and screens

9

2. Health

2.1 Basic Checks

AMST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMST remains at a similar level compared to 1 year ago.
AMST has more shares outstanding than it did 5 years ago.
There is no outstanding debt for AMST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AMST Yearly Shares OutstandingAMST Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
AMST Yearly Total Debt VS Total AssetsAMST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 20.58 indicates that AMST is not in any danger for bankruptcy at the moment.
AMST has a Altman-Z score of 20.58. This is amongst the best in the industry. AMST outperforms 94.44% of its industry peers.
AMST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.58
ROIC/WACCN/A
WACC9.1%
AMST Yearly LT Debt VS Equity VS FCFAMST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 14.95 indicates that AMST has no problem at all paying its short term obligations.
The Current ratio of AMST (14.95) is better than 98.61% of its industry peers.
AMST has a Quick Ratio of 14.95. This indicates that AMST is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of AMST (14.95) is better than 98.61% of its industry peers.
Industry RankSector Rank
Current Ratio 14.95
Quick Ratio 14.95
AMST Yearly Current Assets VS Current LiabilitesAMST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

AMST shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.90%, which is quite good.
Looking at the last year, AMST shows a very negative growth in Revenue. The Revenue has decreased by -68.38% in the last year.
AMST shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.59% yearly.
EPS 1Y (TTM)16.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)-68.38%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.59%
Sales Q2Q%-12.54%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMST Yearly Revenue VS EstimatesAMST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
AMST Yearly EPS VS EstimatesAMST Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AMST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMST Price Earnings VS Forward Price EarningsAMST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMST Per share dataAMST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AMST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMESITE INC

NASDAQ:AMST (6/4/2025, 8:05:07 PM)

After market: 2.8001 -0.12 (-4.11%)

2.92

+0.09 (+3.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-08 2025-05-08
Earnings (Next)09-29 2025-09-29
Inst Owners5.18%
Inst Owner Change105.34%
Ins Owners20.88%
Ins Owner Change2.71%
Market Cap13.34M
Analysts82.86
Price TargetN/A
Short Float %1.75%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 162.94
P/FCF N/A
P/OCF N/A
P/B 3.71
P/tB 4.48
EV/EBITDA N/A
EPS(TTM)-1.36
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.68
FCFYN/A
OCF(TTM)-0.58
OCFYN/A
SpS0.02
BVpS0.79
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -101.57%
ROE -107.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.1%
ROA(5y)-93.27%
ROE(3y)-118.05%
ROE(5y)-118.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.78%
Cap/Sales 537.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.95
Quick Ratio 14.95
Altman-Z 20.58
F-Score3
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)70.4%
Cap/Depr(5y)95.41%
Cap/Sales(3y)125.39%
Cap/Sales(5y)366.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-68.38%
Revenue growth 3Y-37.08%
Revenue growth 5Y75.59%
Sales Q2Q%-12.54%
Revenue Next Year150%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.58%
OCF growth 3YN/A
OCF growth 5YN/A